These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29615501)

  • 21. Blastomyces dermatitidis produces melanin in vitro and during infection.
    Nosanchuk JD; van Duin D; Mandal P; Aisen P; Legendre AM; Casadevall A
    FEMS Microbiol Lett; 2004 Oct; 239(1):187-93. PubMed ID: 15451118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus.
    Yang H; Wu JJ; Tang T; Liu KD; Dai C
    Sci Rep; 2017 Aug; 7(1):7489. PubMed ID: 28790350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient and allele-specific genome editing of disease loci in human iPSCs.
    Smith C; Abalde-Atristain L; He C; Brodsky BR; Braunstein EM; Chaudhari P; Jang YY; Cheng L; Ye Z
    Mol Ther; 2015 Mar; 23(3):570-7. PubMed ID: 25418680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR RNA-guided autonomous delivery of Cas9.
    Wilkinson RA; Martin C; Nemudryi AA; Wiedenheft B
    Nat Struct Mol Biol; 2019 Jan; 26(1):14-24. PubMed ID: 30598555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering Introns to Express RNA Guides for Cas9- and Cpf1-Mediated Multiplex Genome Editing.
    Ding D; Chen K; Chen Y; Li H; Xie K
    Mol Plant; 2018 Apr; 11(4):542-552. PubMed ID: 29462720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dynamic Genome and Transcriptome of the Human Fungal Pathogen Blastomyces and Close Relative Emmonsia.
    Muñoz JF; Gauthier GM; Desjardins CA; Gallo JE; Holder J; Sullivan TD; Marty AJ; Carmen JC; Chen Z; Ding L; Gujja S; Magrini V; Misas E; Mitreva M; Priest M; Saif S; Whiston EA; Young S; Zeng Q; Goldman WE; Mardis ER; Taylor JW; McEwen JG; Clay OK; Klein BS; Cuomo CA
    PLoS Genet; 2015 Oct; 11(10):e1005493. PubMed ID: 26439490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
    He ZY; Men K; Qin Z; Yang Y; Xu T; Wei YQ
    Sci China Life Sci; 2017 May; 60(5):458-467. PubMed ID: 28527117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
    Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in
    Neo DM; Clatworthy AE; Hung DT
    J Bacteriol; 2024 Mar; 206(3):e0033523. PubMed ID: 38319218
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple Applications of a Transient CRISPR-Cas9 Coupled with Electroporation (TRACE) System in the
    Fan Y; Lin X
    Genetics; 2018 Apr; 208(4):1357-1372. PubMed ID: 29444806
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA.
    Zhang X; Jin H; Huang X; Chaurasiya B; Dong D; Shanley TP; Zhao YY
    Cell Rep; 2022 Jan; 38(1):110196. PubMed ID: 34986352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.